Next report date
Report period
Q1 2024
EPS estimate
−1.42USD
Revenue estimate
—
−35.2USD
−112.96 MUSD
1.16 MUSD
6.41 M
About Q32 BIO INC USD0.0001
Sector
Industry
CEO
Jodie P. Morrison
Website
Headquarters
Waltham
Employees (FY)
7
Founded
2017
FIGI
BBG00LPNSNT3
Q32 Bio, Inc. operates as a clinical stage biotechnology company developing biologic therapeutics targeting potent regulators of the innate and adaptive immune systems to re-balance immunity in autoimmune and inflammatory diseases. It focuses on the IL-7 / TSLP receptor pathways and complement system, addressing immune dysregulation to help patients take back control of their lives. The company was founded by David Grayzel and Shelia Violette in 2017 and is headquartered in Waltham, MA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 0T6G is 25.5 USD — it has decreased by 2.18% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange Q32 BIO INC USD0.0001 stocks are traded under the ticker 0T6G.
Q32 BIO INC USD0.0001 is going to release the next earnings report on May 13, 2024. Keep track of upcoming events with our Earnings Calendar.
0T6G stock is 2.23% volatile and has beta coefficient of 0.17. Check out the list of the most volatile stocks — is Q32 BIO INC USD0.0001 there?
0T6G earnings for the last quarter are −10.26 USD per share, whereas the estimation was −7.56 USD resulting in a −35.71% surprise. The estimated earnings for the next quarter are −5.40 USD per share. See more details about Q32 BIO INC USD0.0001 earnings.
Q32 BIO INC USD0.0001 revenue for the last quarter amounts to 354.00 K USD despite the estimated figure of 830.50 K USD. In the next quarter revenue is expected to reach 500.00 K USD.
Yes, you can track Q32 BIO INC USD0.0001 financials in yearly and quarterly reports right on TradingView.
0T6G stock has risen by 10.47% compared to the previous week, the month change is a 91.39% fall, over the last year Q32 BIO INC USD0.0001 has showed a 91.57% decrease.
0T6G net income for the last quarter is −16.12 M USD, while the quarter before that showed −32.95 M USD of net income which accounts for 51.09% change. Track more Q32 BIO INC USD0.0001 financial stats to get the full picture.
Today Q32 BIO INC USD0.0001 has the market capitalization of 336.89 M, it has decreased by 0.68% over the last week.
No, 0T6G doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 0T6G shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Q32 BIO INC USD0.0001 stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 26, 2024, the company has 7.00 employees. See our rating of the largest employees — is Q32 BIO INC USD0.0001 on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Q32 BIO INC USD0.0001 technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Q32 BIO INC USD0.0001 stock shows the sell signal. See more of Q32 BIO INC USD0.0001 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Q32 BIO INC USD0.0001 future price: according to them, 0T6G price has a max estimate of 50.00 USD and a min estimate of 45.00 USD. Read a more detailed Q32 BIO INC USD0.0001 forecast: see what analysts think of Q32 BIO INC USD0.0001 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Q32 BIO INC USD0.0001 EBITDA is −90.82 M USD, and current EBITDA margin is −7.92 K%. See more stats in Q32 BIO INC USD0.0001 financial statements.